Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Esophageal squamous cell carcinoma (ESCC) and colorectal neoplasms (CRNs) share risk factors. We aimed to investigate whether the CRN risk is increased in ESCC patients. Methods: ESCC patients who underwent a colonoscopy within 1 year of diagnosis were retrospectively analyzed. Patients were matched 1:3 by age, gender, and body mass index to asymptomatic controls. CRN was defined as the histological confirmation of adenoma or adenocarcinoma. Advanced CRN was defined as any of the following: ≥3 adenomas, high-grade dysplasia, villous features, tumor ≥1 cm, or adenocarcinoma. The risk factors for both CRN and advanced CRN were evaluated by univariate and multivariate analyses. Results: Sixty ESCC patients were compared with 180 controls. The ESCC group had significantly higher numbers of CRNs (odds ratio [OR], 2.311; 95% confidence interval [CI], 1.265 to 4.220; p=0.006) and advanced CRNs (OR, 2.317; 95% CI, 1.185 to 4.530; p=0.013). Significant risk factors for both CRN and advanced CRN by multivariate analysis included ESCC (OR, 2.157, 95% CI, 1.106 to 4.070, p=0.024; and OR, 2.157, 95% CI, 1.045 to 4.454, p=0.038, respectively) and older age (OR, 1.068, 95% CI, 1.032 to 1.106, p<0.001; and OR, 1.065, 95% CI, 1.024 to 1.109, p=0.002, respectively). Conclusions: The rates of CRN and advanced CRN are significantly increased in ESCC. Colonoscopy should be considered at ESCC diagnosis.
Abstract
Background/Aims: Esophageal squamous cell carcinoma (ESCC) and colorectal neoplasms (CRNs) share risk factors. We aimed to investigate whether the CRN risk is increased in ESCC patients. Methods: ESCC patients who underwent a colonoscopy within 1 year of diagnosis were retrospectively analyzed. Patients were matched 1:3 by age, gender, and body mass index to asymptomatic controls. CRN was defined as the histological confirmation of adenoma or adenocarcinoma. Advanced CRN was defined as any of the following: ≥3 adenomas, high-grade dysplasia, villous features, tumor ≥1 cm, or adenocarcinoma. The risk factors for both CRN and advanced CRN were evaluated by univariate and multivariate analyses. Results: Sixty ESCC patients were compared with 180 controls. The ESCC group had significantly higher numbers of CRNs (odds ratio [OR], 2.311; 95% confidence interval [CI], 1.265 to 4.220; p=0.006) and advanced CRNs (OR, 2.317; 95% CI, 1.185 to 4.530; p=0.013). Significant risk factors for both CRN and advanced CRN by multivariate analysis included ESCC (OR, 2.157, 95% CI, 1.106 to 4.070, p=0.024; and OR, 2.157, 95% CI, 1.045 to 4.454, p=0.038, respectively) and older age (OR, 1.068, 95% CI, 1.032 to 1.106, p<0.001; and OR, 1.065, 95% CI, 1.024 to 1.109, p=0.002, respectively). Conclusions: The rates of CRN and advanced CRN are significantly increased in ESCC. Colonoscopy should be considered at ESCC diagnosis.
참고문헌 (49)
- Kamangar F, "Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world", J Clin Oncol, 24, pp.2137~2150 (2006)
- Jemal A, "Cancer statistics, 2010", CA Cancer J Clin, 60, pp.277~300 (2010)
- Davila ML, "Endoscopic management of Barrett’s esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma", Thorac Surg Clin, 23, pp.479~489 (2013)
- Pech O, "Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus", Gut, 57, pp.1200~1206 (2008)
- Smithers BM, "Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer", Thorac Surg Clin, 23, pp.509~523 (2013)
- van Hagen P, "Preoperative chemoradiotherapy for esophageal or junctional cancer", N Engl J Med, 366, pp.2074~2084 (2012)
- Nandy N, "Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review", Curr Med Res Opin, 29, pp.1055~1065 (2013)
- Poon RT, "Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications", Ann Thorac Surg, 65, pp.1529~1534 (1998)
- Chuang SC, "Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries", Cancer Epidemiol Biomarkers Prev, 17, pp.1543~1549 (2008)
- Kumagai Y, "Multiple primary cancers associated with esophageal carcinoma", Surg Today, 31, pp.872~876 (2001)
- Zhu G, "Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries", Dis Esophagus, 25, pp.505~511 (2012)
- Natsugoe S, "Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome", World J Surg, 29, pp.46~49 (2005)
- Bollschweiler E, "High prevalence of colonic polyps in white males with esophageal adenocarcinoma", Dis Colon Rectum, 52, pp.299~304 (2009)
- Siersema PD, "Colorectal neoplasia in veterans is associated with Barrett’s esophagus but not with proton-pump inhibitor or aspirin", NSAID use, 2006, pp.63, 581~586
- Miyazaki T, "Clinical significance of total colonoscopy for screening of colon lesions in patients with esophageal cancer", Anticancer Res, 33, pp.5113~5117 (2013)
- Kuwano H, "Oesophageal cancer coexisting with colorectal lesions", Eur J Surg, 162, pp.797~800 (1996)
- Leers JM, "Preoperative colonoscopy before esophagectomy and reconstruction with gastric interposition", Chirurg, 75, pp.1210~1214 (2004)
- Anderson JC, "Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population", Am J Gastroenterol, 100, pp.2049~2055 (2005)
- Anderson JC, "Prevalence of colorectal neoplasia in smokers", Am J Gastroenterol, 98, pp.2777~2783 (2003)
- Qu X, "Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis", Ann Epidemiol, 23, pp.762~770 (2013)
- Lin Y, "Epidemiology of esophageal cancer in Japan and China", J Epidemiol, 23, pp.233~242 (2013)
- Watson AJ, "Colon cancer: a civilization disorder", Dig Dis, 29, pp.222~228 (2011)
- Fearon ER, "A genetic model for colorectal tumorigenesis", Cell, 61, pp.759~767 (1990)
- Maesawa C, "Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma", Int J Cancer, 57, pp.21~25 (1994)
- Kato H, "Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers", Cancer Lett, 167, pp.65~72 (2001)
- Lyronis ID, "K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma", Pathol Oncol Res, 14, pp.267~273 (2008)
- Gopalswamy N, "Is in vivo measurement of size of polyps during colonoscopy accurate?", Gastrointest Endosc, 46, pp.497~502 (1997)
- Lieberman DA, "Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer", Gastroenterology, 143, pp.844~857 (2012)
- Rice TW, "7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction", Ann Surg Oncol, 17, pp.1721~1724 (2010)
- Vaughan TL, "Colorectal cancer in patients with esophageal adenocarcinoma", Cancer Epidemiol Biomarkers Prev, 4, pp.93~97 (1995)
- Sonnenberg A, "Barrett’s metaplasia and colonic neoplasms: a significant association in a 203,534-patient study", Dig Dis Sci, 58, pp.2046~2051 (2013)
- Kolligs FT, "Risk of advanced colorectal neoplasia according to age and gender", PLoS One, 6, pp.e20076~ (2011)
- Rabeneck L, "Advanced proximal neoplasia of the colon in average-risk adults", Gastrointest Endosc, 80, pp.660~667 (2014)
- Alexandre L, "Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis", Gastroenterology, 146, pp.661~668 (2014)
- Sandler RS, "A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer", N Engl J Med, 348, pp.883~890 (2003)
- Siddiqui AA, "The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps", Digestion, 79, pp.17~22 (2009)
- Sun L, "Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma", Dis Esophagus, 24, pp.544~549 (2011)
- Fong SF, "Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors", Genes Chromosomes Cancer, 46, pp.644~655 (2007)
- Liu JF, "Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus", Dis Esophagus, 19, pp.350~354 (2006)
- Roelofs HM, "Over-expression of COX-2 mRNA in colorectal cancer", BMC Gastroenterol, 14, pp.1~ (2014)
- Kishikawa H, "Incidence and risk factors for colorectal neoplasia in patients with oral squamous cell carcinoma", Colorectal Dis, 16, pp.888~895 (2014)
- Diamond SJ, "Adenoma detection rate increases with each decade of life after 50 years of age", Gastrointest Endosc, 74, pp.135~140 (2011)
- Hong SN, "Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age", Gastrointest Endosc, 72, pp.480~489 (2010)
- Stein B, "Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population", Dig Dis Sci, 55, pp.2945~2952 (2010)
- Bayerdörffer E, "Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas", Ann Intern Med, 118, pp.481~487 (1993)
- Deng L, "Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis", Dig Dis Sci, 57, pp.1576~1585 (2012)
- Yang MH, "The association of serum lipids with colorectal adenomas", Am J Gastroenterol, 108, pp.833~841 (2013)
- Rex DK, "Quality indicators for colonoscopy", Am J Gastroenterol, 101, pp.873~885 (2006)
- Zauber AG, "Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths", N Engl J Med, 366, pp.687~696 (2012)